What's new in cardiac pacing in children?

Jan Janoušek1, Peter Kubuš

  • 1Children's Heart Centre, University Hospital Motol, Prague, Czech Republic.

Insights

Recent advancements in pediatric cardiac pacing and implantable cardioverter-defibrillator (ICD) therapy focus on optimizing ventricular function and lead placement. Future improvements depend on technical refinements and tailored therapy indications for better outcomes in children.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Electrophysiology
  • Biomedical Engineering

Background:

  • Pediatric cardiac pacing and implantable cardioverter-defibrillator (ICD) therapy are evolving fields.
  • Understanding the impact of pacing on ventricular function is crucial for pediatric patients.

Purpose of the Study:

  • To review and prioritize recent data on pediatric cardiac pacing published within the last 18 months.
  • To provide insights into current developments and future directions in the field.

Main Methods:

  • Literature review of recent publications on pediatric cardiac pacing and ICD therapy.
  • Analysis of data focusing on ventricular function, lead survival, and therapeutic indications.

Main Results:

  • Pacing site significantly influences left ventricular (LV) function and synchrony in pediatric patients.
  • Endocardial leads demonstrate survival superiority over epicardial leads, though technical refinements may improve long-term epicardial outcomes.
  • Recent guideline changes for cardiac resynchronization therapy (CRT) in adults may impact pediatric indications.
  • New data shed light on ICD lead survival and the use of ICDs in young patients with hypertrophic cardiomyopathy.

Conclusions:

  • Pediatric cardiac pacing and ICD therapy are advancing with technical improvements, optimized lead placement, and refined indications.
  • Continued research and development are expected to enhance treatment efficacy and patient outcomes.
Abstract

Related Concept Videos

Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.7K